Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial
Initial analysis of the Assessment of Proteasome Inhibition for Extending Remissions (APEX) trial of relapsed multiple myeloma patients showed significantly longer time to progression, higher response rate, and improved survival with single-agent bortezomib versus high-dose dexamethasone. In this up...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
[15 November 2007]
|
| In: |
Blood
Year: 2007, Volume: 110, Issue: 10, Pages: 3557-3560 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2006-08-036947 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2006-08-036947 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0006497120422608 |
| Author Notes: | Paul G. Richardson, Pieter Sonneveld, Michael Schuster, David Irwin, Edward Stadtmauer, Thierry Facon, Jean-Luc Harousseau, Dina Ben-Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Jesus San Miguel, Joan Bladé, Mario Boccadoro, Jamie Cavenagh, Melissa Alsina, S. Vincent Rajkumar, Martha Lacy, Andrzej Jakubowiak, William Dalton, Anthony Boral, Dixie-Lee Esseltine, David Schenkein, and Kenneth C. Anderson |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1786940892 | ||
| 003 | DE-627 | ||
| 005 | 20220820112705.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220121s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood-2006-08-036947 |2 doi | |
| 035 | |a (DE-627)1786940892 | ||
| 035 | |a (DE-599)KXP1786940892 | ||
| 035 | |a (OCoLC)1341439033 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Richardson, Paul G. |e VerfasserIn |0 (DE-588)1073660222 |0 (DE-627)829311114 |0 (DE-576)435237594 |4 aut | |
| 245 | 1 | 0 | |a Extended follow-up of a phase 3 trial in relapsed multiple myeloma |b final time-to-event results of the APEX trial |c Paul G. Richardson, Pieter Sonneveld, Michael Schuster, David Irwin, Edward Stadtmauer, Thierry Facon, Jean-Luc Harousseau, Dina Ben-Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Jesus San Miguel, Joan Bladé, Mario Boccadoro, Jamie Cavenagh, Melissa Alsina, S. Vincent Rajkumar, Martha Lacy, Andrzej Jakubowiak, William Dalton, Anthony Boral, Dixie-Lee Esseltine, David Schenkein, and Kenneth C. Anderson |
| 264 | 1 | |c [15 November 2007] | |
| 300 | |b Diagramme | ||
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.01.2022 | ||
| 520 | |a Initial analysis of the Assessment of Proteasome Inhibition for Extending Remissions (APEX) trial of relapsed multiple myeloma patients showed significantly longer time to progression, higher response rate, and improved survival with single-agent bortezomib versus high-dose dexamethasone. In this updated analysis (median follow-up: 22 months), survival was assessed in both arms, and efficacy updated for the bortezomib arm. Median survival was 29.8 months for bortezomib versus 23.7 months for dexamethasone, a 6-month benefit, despite substantial crossover from dexamethasone to bortezomib. Overall and complete response rates with bortezomib were 43% and 9%, respectively; among responding patients, 56% improved response with longer therapy beyond initial response, leading to continued improvement in overall quality of response. Higher response quality (100% M-protein reduction) was associated with longer response duration; response duration was not associated with time to response. These data confirm the activity of bortezomib and support extended treatment in relapsed multiple myeloma patients tolerating therapy. This study is registered at http://clinicaltrials.gov (Study ID NCT00048230). | ||
| 700 | 1 | |a Sonneveld, Pieter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schuster, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Irwin, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stadtmauer, Edward |e VerfasserIn |4 aut | |
| 700 | 1 | |a Facon, Thierry |e VerfasserIn |4 aut | |
| 700 | 1 | |a Harousseau, Jean-Luc |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ben-Yehuda, Dina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lonial, Sagar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Reece, Donna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Miguel, Jesus San |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bladé, Joan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Boccadoro, Mario |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cavenagh, Jamie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Alsina, Melissa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rajkumar, S. Vincent |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lacy, Martha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jakubowiak, Andrzej |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dalton, William |e VerfasserIn |4 aut | |
| 700 | 1 | |a Boral, Anthony |e VerfasserIn |4 aut | |
| 700 | 1 | |a Esseltine, Dixie-Lee |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schenkein, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Anderson, Kenneth C. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 110(2007), 10, Seite 3557-3560 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Extended follow-up of a phase 3 trial in relapsed multiple myeloma final time-to-event results of the APEX trial |
| 773 | 1 | 8 | |g volume:110 |g year:2007 |g number:10 |g pages:3557-3560 |g extent:4 |a Extended follow-up of a phase 3 trial in relapsed multiple myeloma final time-to-event results of the APEX trial |
| 856 | 4 | 0 | |u https://doi.org/10.1182/blood-2006-08-036947 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0006497120422608 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220121 | ||
| 993 | |a Article | ||
| 994 | |a 2007 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 10 | ||
| 999 | |a KXP-PPN1786940892 |e 4040848004 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1786940892"],"doi":["10.1182/blood-2006-08-036947"]},"relHost":[{"note":["Gesehen am 21.04.2023"],"origin":[{"publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedKey":"1946","dateIssuedDisp":"1946-","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Blood online"}],"title":[{"title_sort":"Blood","subtitle":"journal of the American Society of Hematology","title":"Blood"}],"part":{"issue":"10","volume":"110","extent":"4","pages":"3557-3560","text":"110(2007), 10, Seite 3557-3560","year":"2007"},"language":["eng"],"corporate":[{"role":"isb","display":"American Society of Hematology"}],"disp":"Extended follow-up of a phase 3 trial in relapsed multiple myeloma final time-to-event results of the APEX trialBlood","id":{"zdb":["1468538-3"],"issn":["1528-0020"],"eki":["266886647"]},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1946 -"],"recId":"266886647"}],"recId":"1786940892","physDesc":[{"extent":"4 S.","noteIll":"Diagramme"}],"name":{"displayForm":["Paul G. Richardson, Pieter Sonneveld, Michael Schuster, David Irwin, Edward Stadtmauer, Thierry Facon, Jean-Luc Harousseau, Dina Ben-Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Jesus San Miguel, Joan Bladé, Mario Boccadoro, Jamie Cavenagh, Melissa Alsina, S. Vincent Rajkumar, Martha Lacy, Andrzej Jakubowiak, William Dalton, Anthony Boral, Dixie-Lee Esseltine, David Schenkein, and Kenneth C. Anderson"]},"language":["eng"],"title":[{"title":"Extended follow-up of a phase 3 trial in relapsed multiple myeloma","title_sort":"Extended follow-up of a phase 3 trial in relapsed multiple myeloma","subtitle":"final time-to-event results of the APEX trial"}],"note":["Gesehen am 21.01.2022"],"origin":[{"dateIssuedDisp":"[15 November 2007]","dateIssuedKey":"2007"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"aut","given":"Paul G.","display":"Richardson, Paul G.","family":"Richardson"},{"given":"Pieter","role":"aut","family":"Sonneveld","display":"Sonneveld, Pieter"},{"display":"Schuster, Michael","family":"Schuster","role":"aut","given":"Michael"},{"given":"David","role":"aut","display":"Irwin, David","family":"Irwin"},{"role":"aut","given":"Edward","family":"Stadtmauer","display":"Stadtmauer, Edward"},{"family":"Facon","display":"Facon, Thierry","given":"Thierry","role":"aut"},{"family":"Harousseau","display":"Harousseau, Jean-Luc","given":"Jean-Luc","role":"aut"},{"family":"Ben-Yehuda","display":"Ben-Yehuda, Dina","role":"aut","given":"Dina"},{"role":"aut","given":"Sagar","display":"Lonial, Sagar","family":"Lonial"},{"role":"aut","given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"given":"Donna","role":"aut","family":"Reece","display":"Reece, Donna"},{"display":"Miguel, Jesus San","family":"Miguel","role":"aut","given":"Jesus San"},{"role":"aut","given":"Joan","family":"Bladé","display":"Bladé, Joan"},{"given":"Mario","role":"aut","display":"Boccadoro, Mario","family":"Boccadoro"},{"family":"Cavenagh","display":"Cavenagh, Jamie","given":"Jamie","role":"aut"},{"family":"Alsina","display":"Alsina, Melissa","role":"aut","given":"Melissa"},{"role":"aut","given":"S. Vincent","display":"Rajkumar, S. Vincent","family":"Rajkumar"},{"role":"aut","given":"Martha","display":"Lacy, Martha","family":"Lacy"},{"role":"aut","given":"Andrzej","family":"Jakubowiak","display":"Jakubowiak, Andrzej"},{"role":"aut","given":"William","display":"Dalton, William","family":"Dalton"},{"display":"Boral, Anthony","family":"Boral","given":"Anthony","role":"aut"},{"given":"Dixie-Lee","role":"aut","display":"Esseltine, Dixie-Lee","family":"Esseltine"},{"role":"aut","given":"David","family":"Schenkein","display":"Schenkein, David"},{"family":"Anderson","display":"Anderson, Kenneth C.","given":"Kenneth C.","role":"aut"}]} | ||
| SRT | |a RICHARDSONEXTENDEDFO1520 | ||